Physicochemical differences between camelid single-domain antibodies and mammalian antibodies

被引:1
|
作者
Eskier, Nazli Eda [1 ,2 ]
Eskier, Doga [1 ,2 ]
Firuzan, Esin [3 ]
Uzunlar, Sibel Kalyoncu [2 ]
机构
[1] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, Izmir, Turkiye
[2] Izmir Biomed & Genome Ctr, Izmir, Turkiye
[3] Dokuz Eylul Univ, Fac Sci, Dept Stat, Izmir, Turkiye
关键词
Antibody; nanobody; camelid; physicochemical properties; logistic regression; machine learning; DISULFIDE BOND; SEQUENCE; VHH; PREDICTION; NANOBODIES; STABILITY; COMPLEX; SDAB;
D O I
10.55730/1300-0152.2676
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background/aim: In recent years, single-domain antibodies, also known as nanobodies, have emerged as an alternative to full immunoglobulin Gs (IgGs), due to their various advantages, including increased solubility, faster clearance, and cheaper production. Nanobodies are generally derived from the variable domain of the camelid heavy-chain-only immunoglobulin Gs (hcIgGs). Due to the high sequence homology between variable heavy chains of camelids (VHHs) and humans (VHs), hcIgGs are ideal candidates for nanobody development. However, further examination is needed to understand the structural differences between VHs and VHHs. This analysis is essential for nanobody engineering to mitigate potential immunogenicity, while preserving stability, functionality, and antigen specificity.Materials and methods: We obtained the VH and VHH sequences of various camelid and non-camelid mammalian antibodies from public databases and used multiple sequence alignment based on the Chothia numbering scheme. Aligned sequences were subjected to diverse analyses encompassing paratope length, binding prediction, motif, disulfide bridge, salt bridge profiling, and physicochemical characteristic distribution. Logistic Regression coupled with the Boruta -Random Forest algorithm facilitated the comprehensive examination of physicochemical properties. Results: Our findings revealed longer, less variable paratope sequences in VHHs, along with specific antigen binding residues with increased binding potential compared to VHs. Although the VHs showed more heterogeneous noncanonical disulfide bond patterns, the VHHs had a higher number of noncanonical disulfide bridges. Intriguingly, a typical salt bridge between the 94th and 101st positions in the VHs had a very low encounter rate in the VHHs. Surprisingly, we also identified notable differences in the physicochemical patterns of mostly conserved frameworks (FWs), especially the FW2 and FW3 regions, between VHs and VHHs.Conclusion: Our findings point to possible key sites in VHHs as candidate residues for nanobody engineering efforts.
引用
收藏
页数:27
相关论文
共 50 条
  • [31] Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of neglected Tropical Diseases
    Fernandes, Carla F. C.
    Pereira, Soraya dos S.
    Luiz, Marcos B.
    Zuliani, Juliana P.
    Furtado, Gilvan P.
    Stabeli, Rodrigo G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [32] Single-domain antibodies applied as antiviral immunotherapeutics
    Reis Prado, Nidiane Dantas
    Brilhante-Da-Silva, Nairo
    Oliveira Sousa, Rosa Maria
    da Silva Morais, Michelle Suelen
    Roberto, Sibele Andrade
    Luiz, Marcos Barros
    de Assis, Livia Coelho
    Marinho, Anna Carolina M.
    Lemes de Araujo, Luiz Felipe
    Pontes, Rafael de Souza
    Stabeli, Rodrigo Guerino
    Celedonio Fernandes, Carla Freire
    Pereira, Soraya dos Santos
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2023, 320
  • [33] Improving the targeting of therapeutics with single-domain antibodies
    Turner, Kendrick B.
    Alves, Nathan J.
    Medintz, Igor L.
    Walper, Scott A.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (04) : 561 - 570
  • [34] Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview
    Goldman, Ellen R.
    Liu, Jinny L.
    Zabetakis, Dan
    Anderson, George P.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [35] Preparation and characterization of novel IgG affinity resin coupling anti-Fc camelid single-domain antibodies
    Tu, Zhui
    Xu, Yang
    Fu, Jinheng
    Huang, Zhibing
    Wang, Yao
    Liu, Bin
    Tao, Yong
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2015, 983 : 26 - 31
  • [36] A new generation of anti-hapten antibodies:: Single-domain llama antibodies
    Alvarez, N.
    Behar, G.
    Baty, D.
    Barbet, J.
    Aubry, J.
    Birkle, S.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (04) : 399 - 399
  • [37] Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
    Puttemans, Janik
    Dekempeneer, Yana
    Eersels, Jos L.
    Hanssens, Heleen
    Debie, Pieterjan
    Keyaerts, Marleen
    Windhorst, Albert D.
    van der Aa, Frank
    Lecocq, Quentin
    Breckpot, Karine
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Lahoutte, Tony
    Devoogdt, Nick
    D'Huyvetter, Matthias
    [J]. CANCERS, 2020, 12 (04)
  • [38] Application of Single-Domain Antibodies ("Nanobodies") to Laboratory Diagnosis
    Pillay, Tahir S.
    Muyldermans, Serge
    [J]. ANNALS OF LABORATORY MEDICINE, 2021, 41 (06) : 549 - 558
  • [39] Single-domain antibodies as therapeutics for solid tumor treatment
    Wang, Mingkai
    Ying, Tianlei
    Wu, Yanling
    [J]. ACTA PHARMACEUTICA SINICA B, 2024, 14 (07) : 2854 - 2868
  • [40] Promises and challenges of single-domain antibodies to control influenza
    Matthys, Arne
    Saelens, Xavier
    [J]. ANTIVIRAL RESEARCH, 2024, 222